Leading cyber security software specialist, ZoneFox, has been sold by its shareholders – including Scottish business angel investment syndicates, Archangels and TriCap, Scottish Investment Bank and Napier University – to US-based Fortinet.
Co-lead investment in Optoscribe from Archangels and Maven set to facilitate increase in manufacturing capacity and engineering resource, to meet customer demand.
MGB Biopharma’s anti-bacterial agent for treatment of C. difficile infections, helped by Archangels funding round, to enter Phase II clinical trials
The role of Archangels in supporting Scottish companies to scale-up will be highlighted at the investment syndicate’s annual dinner, Chorus 2018.
Archangels, SIB, & BDD complete a £2m funding round designed to enable BDD to scale its business, focusing on its precision timed drug delivery system.
PhysioMedics, the Scottish early stage company that has developed a revolutionary online self-assessment platform…
David Ovens, Chief Operating Officer at Archangels, the oldest & one of the largest business angel investment syndicates in the world, comments on budget
WaveLIFT Limited announces that it has secured funding of over £1 million to develop its innovative Artificial Lift pump technology for the oil and gas sector.
Over 180 investors and entrepreneurs will gather tonight (Tuesday, 25th April, 2017) to celebrate a quarter of a century of early stage investing by business angel syndicate, Archangels, and will hear that the syndicate has led more than £222m of investment by Archangels and its partners in 82 Scottish companies, creating over 3,500 high value jobs since launching in 1992.
A novel antibiotic, which has been developed in Scotland for the treatment of Clostridium difficile, will take a step closer to being brought to market following the completion of a further round of funding led by prominent angel investment syndicate, Archangels, for MGB Biopharma (MGB).
Reactec, the market leader in monitoring and management support solutions for hand and arm vibration syndrome (HAVS) – one of the most common industrial diseases in the UK – has completed a further £700,000 round of fundraising for the ongoing development of its innovative HAVwear personal monitoring equipment and reporting technology.
Scottish-based business angel syndicate, Archangels, has appointed Shaolei McKie as its Investment Executive.
- Page 1 of 2